Drug

Why Amgen’s Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemy

After the Federal Trade Commission (FTC) demanded Bristol-Myers Squibb (NYSE:BMY) sell its blockbuster Otezla to secure approval for its $74 billion acquisition of Celgene (NASDAQ:CELG), a bidding war resulted in Amgen (NASDAQ:AMGN) agreeing

Drug

Trump’s drug pricing blueprint hits a speed bump

The Trump administration’s efforts to lower drug prices hit two significant hitches last week. On Monday, a federal judge in Washington struck down a rule the Department

Drug

Veterans Affairs Approves ‘Ketamine-Like’ Drug Despite Cost, Doctors’ Misgivings: Reports

Robert Wilkie, secretary of Veterans Affairs (VA), speaks during an event supporting veterans and military families in the Eisenhower Executive Office Building in Washington, D.C.,

Drug

Existing drug for blood problems is used to treat vitiligo

Despite some promising research, there is currently no one reliable cure for vitiligo. There may be new hope, however, as a recent study has shown an

Drug

Colluding drug firms ‘cost the NHS millions of pounds’

Four pharmaceutical firms have been accused of illegally colluding to restrict the supply of an anti-nausea tablet, driving the price paid for it by the

Drug

Pfizer Denies Encouraging Drug Abuse By Packaging Fentanyl With Cooking Spoon, Lighter

NEW YORK—In an effort to address the growing controversy surrounding widespread non-medical use of their products, pharmaceutical giant Pfizer released a statement Thursday categorically denying

Drug

Has Trump Actually Done Anything About Drug Prices?

Donald Trump’s promise of sweeping health-care reform has not come to pass. While the president campaigned heavily on assurances to “repeal and replace Obamacare” on

Drug

The Drug Pipeline: How do narcotics end up in our valley?

LAS VEGAS (KSNV) — The Drug Enforcement Administration (DEA) says that the Las Vegas valley is a unique spot for drug trafficking as a big market

Drug

ICER’s Growing Impact On Drug Pricing And Reimbursement

CVS Caremark President and CVS Health Executive Vice President Derica Rice testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9,

Drug

MRPs of 390 cancer medicines cut by 87% after price control order

New Delhi: The maximum retail price (MRP) of 390 non-scheduled cancer medicines have been reduced by up to 87%, the government said Friday, days after India’s

Please follow & like us

RSS
Follow by Email
Facebook
Google+
Twitter